Market Research Blog – Page 1940 – New Product Development

Smart Bed Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2033

The global smart bed market size is expected to be valued at USD 3.42 Billion in 2023. With the rise in the purchase of luxury and comfortable products, due to increasing disposable income, coupled with the rising awareness about the benefits of smart beds, the overall demand for smart beds is projected to grow at a CAGR of 7.0% between 2023 and 2033, totalling around USD 6.73 Billion by 2033.

The increasing utilization of smart beds in the healthcare industry, due to the increasing automation and improving patient room technology is one of the major factors that is expected to boost the growth of the smart bed market during the forecast period.

In addition, rising investments in the healthcare sector by governing agencies of different countries, coupled with the growing geriatric population, have positively influenced the installation of smart beds across the globe. These beds provide a wide range of benefits, including smart fabric technology, automatic mattress firmness adjustments, anti-snoring features, adjustable bases, and smart-home connectivity, which is further anticipated to fuel overall sales.

There are a huge number of fresh entrants who are laser-focused on meeting the changing consumer demands globally, and these companies have penetrated the online channels to gain an edge over the competitors in the market. The fast-paced competition has created ample options for the consumers to select their products, which have shifted the product purchase behaviour.

Furthermore, the prominent manufacturers’ product innovations have helped the market meet the demand from the hospitality sector. Stryker Corporation, in October 2020, launched a smart bed named ‘ProCuity’ that comes with smart embedded features and sensors, including Stryker’s Secure Connect Technology for smart patient monitoring and to connect to nurse call systems wirelessly.

Key Takeaways from the Market Study

Global smart bed market was valued at US$ 3.2 Billion by 2022-end
From 2018 to 2022, the market demand expanded at a CAGR of 7%
By application, the hospital segment of the market constitutes the bulk of the market with a market share of 32%
By distribution channel, the offline segment dominates the market with a share of 30%
From 2023 to 2033, Smart Bed sales are expected to flourish at a CAGR of 0%.
By 2033, the market value of Smart Bed is expected to reach US$ 73 Billion

“The demand for smart home devices and gadgets is soaring and the escalating consumer interest towards such smart home gadgets is uplifting the consumption of such products across households,” remarks an FMI analyst.

Competitive Landscape

Players in the global Smart Bed Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In September 2021, Baxter International Inc., an American multinational health care company, acquired Hill-Rom Holdings, Inc. for a $10.5 billion total equity value. This acquisition by Baxter adds smart hospital beds to its existing product portfolio of patient monitoring and diagnostic products. Hill-Rom Holdings, Inc. is a medical device provider based in the USA.
In August 2020, Sleep Number made advancements to its 360 Smart Bed with SleepIQ technology. The beds are designed to conform more closely to the body for superior support and spinal alignment, increased pressure relief, and reduced motion transfer.
ReST and Purple Innovation, the innovators behind the renowned Purple Grid, partnered in July 2020. The ReST smart bed incorporates both smart technology and comfort technologies to create a different kind of sleep.

Know More About What the Smart Bed Market Report Covers

Future Market Insights offers an unbiased analysis of the global Smart Bed Market, providing historical data for 2018-2022 and forecast statistics from 2023-2033.

To understand opportunities in the smart bed market, the market is segmented on the basis of application, and distribution channels across five major regions.

Key Segments Covered in the Smart Bed Industry Analysis

Smart Bed Market by Application:

Residential
Hospital
Hospitality
Others

Smart Bed Market by Distribution Channel:

Supermarkets/Hypermarkets
Specialty Stores
Online
Others

Smart Bed Market by Region:

North America
Europe
Asia Pacific
Central & South America
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

COVID-19 Saliva Sampling Test Potential Market Poised for Steady Growth at 5.1% CAGR, Reaching US$5.4 Billion by 2032 | FMI Study

The COVID-19 Saliva Sampling Test Potential Market is experiencing a stable rise, fueled by the emergence of new and more transmissible SARS-CoV-2 variants, according to a recent report by Future Market Insights (FMI), a leading market research firm. This trend underscores the ongoing need for efficient and convenient testing methods to effectively manage the COVID-19 pandemic.

FMI’s in-depth market analysis reveals that the market, valued at US$3.1 billion in 2021, is projected to reach US$5.4 billion by 2032. This signifies a steady Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period.

The key driver behind this anticipated growth is the prominence of fluorescence-labeled antigen/antibody testing, projected to exhibit the highest CAGR of over 5.1%. This testing method offers a range of advantages, including user-friendliness, a shorter test-to-result timeline, and a patient-friendly nature.

Request a Sample of this Report Now Use Work Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14945

The market for COVID-19 Saliva Sampling Test Potential is dominated by companies such as ARUP Laboratories, Vatic Health, Mogene, Psomagen Inc, and DxTerity Diagnostics Inc. North American region has become the world’s leading market for COVID-19 saliva Sampling tests due to the introduction of several new products by emerging companies, as well as the presence of homegrown firms that manufacture diagnostic and Sampling tests based on various technologies.

Centralized Testing commanded the highest growth through the forecast period of 2022-2032 with a CAGR of 5.1%. Some of the main reasons for the strong emphasis on saliva-based COVID-19 diagnosis across centralized settings are the ease of use of sample collection, reduction in the amount of supplies necessary for saliva testing, and reduction in testing procedures.

Key Takeaways from the COVID-19 Saliva Sampling Test Potential Market Study

The COVID-19 Saliva Sampling Test Potential market is anticipated to add 1.6X value by 2032.
The market is expected to expand at a considerable growth rate of 5.1% and be valued at US$ 5.4 Bn by 2032.
ARUP Laboratories, Vatic Health, Mogene, Psomagen Inc., and DxTerity Diagnostics Inc. are the top giants in COVID-19 Saliva Sampling Test Potential manufacturing.
Based on technology, the Fluorescence-labelled antigen/antibodies Testing segment accounted for the majority of the global COVID-19 Saliva Sampling Test Potential market share in 2021.
In April 2021, Vatic Health received the CE mark for its on-the-spot SARS-CoV-2 virus saliva antigen test. The test has also been registered with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom. Several major players are concentrating on advancements in in-vitro diagnostic procedures with rapid testing, as well as expanding their product portfolios.

“Saliva-based tests are crucial in sampling asymptomatic individuals, which will aid in market revenue generation shortly.” says a Future Market Insights analyst.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global COVID-19 Saliva Sampling Test Potential market, presenting historical market data (2019-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities and Colleges, and Factories), Technology (Fluorescence-labelled antigen/antibodies Testing, RT-PCR and CRISPR-Cas9), Mode (Centralized Testing and Decentralized Testing) and Region (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)

COVID-19 Saliva Sampling Test Potential Market Key Companies Profiled

ARUP Laboratories
Vatic Health
Mogene
Psomagen Inc
DxTerity Diagnostics Inc
Chembio Diagnostics
Abbott

Purchase a Complete Research Report
https://www.futuremarketinsights.com/checkout/14945

Segments Covered in COVID-19 Saliva Sampling Test Potential Market Analysis

By Location:

Travel Stations
Sports Arenas
Entertainment Venues
Corporate Campus Environments
Universities & Colleges
Factories

By Technology:

Fluorescence-labeled antigen/antibodies testing
RT-PCR
CRISPR-Cas9

By Mode:

Centralized Testing
Decentralized Testing

By Region:

North America
Latin America
Europe
APAC
MEA

Future Market Insights’s Domain Knowledge in Healthcare Division

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hard Gelatin Capsules Market Poised to Swallow Up US$3.2 Billion by 2032, Growing at a 6.4% CAGR | FMI Study

The Hard Gelatin Capsules Market is on the cusp of a significant expansion, propelled by the ever-increasing demand for pharmaceuticals worldwide. A recent industry analysis predicts a staggering market valuation of US$3.2 billion by 2032. This impressive growth trajectory translates to a robust Compound Annual Growth Rate (CAGR) of 6.4% over the next decade, solidifying the enduring significance of hard gelatin capsules within the pharmaceutical industry.

Hard gelatin capsules, recognized as a pivotal oral dosage form, have played an instrumental role in delivering a diverse range of supplements. From essential minerals to life-saving medications, vitamins, and various health-enhancing compounds, these capsules have become indispensable in the realm of modern pharmaceuticals. Originally designed as single-dose formulations for administering powdered or granulated medications, they have evolved into a cornerstone of pharmaceutical innovation.

The landscape of capsule-based drug delivery systems has witnessed a transformative renaissance, driven by the innovative introduction of pellet technology. This breakthrough allows for the integration of multi-particulate drug delivery within the capsule, leading to a paradigm shift in therapeutic efficacy.

Request a Sample of this Report Now Use Work Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14948

Liquid-filled hard gelatin capsules have emerged as a compelling alternative to their soft gelatin counterparts. Many industry players have adopted liquid encapsulation technology previously associated with soft gels. Formulation experts are revisiting two-piece hard gelatin capsules as a viable substitute for soft gels, positioning them for greater use and innovation in the pharmaceutical field.

The gelatin on hard caps makes it simpler for consumers to swallow at the time of safeguarding active ingredients in a capsule from light, oxygen, and dust.

The good part is that empty capsules could be sold to the brand owners who would fill them with nutrition or drugs. Plus, providers of gelatin provide Kosher and Halal certifications for several gelatin varieties for catering to consumers’ needs.

However, the fact that hard gelatin capsule shells are prone to gelatin’s cross-linking; could, in turn, result in all the more mutable rates to render in-vitro dissolution. Though the issue could be resolved by adding proteolytic enzymes to the dissolving medium, but comes with complications; which results in very few regulatory bodies approving it.

Future Market Insights has entailed these facets with future prospects in its latest market study entitled ‘Global Hard Gelatin Capsules Industry’. It has its team of analysts and consultants to execute using a bottom-up approach in its primary, secondary, and tertiary modes of research.

“Oral administration is expected to be the major revenue generator of the Global Hard Gelatin Capsules Industry going forward”, says an analyst from Future Market Insights.

Key Takeaways from the Hard Gelatin Capsules Market

North America holds the largest market share with the US being subject to extensive research being conducted due to funds backed by the government.
Europe holds the second-largest market share with Germany leading from the front. This could be reasoned with regulated manufacturing as well as development of the nutraceuticals through new modes of drug delivery.
The Asia-Pacific is expected to grow at the fastest rate in the Global Hard Gelatin Capsules Industry. This could be credited to China dominating the market. It is coming through as a production hub for various pharmaceutical products. Thus high-functioning manufacturing units are coming up with contract manufacturing.

Competitive Hard Gelatin Capsules Market

Medicaps, in March 2022, did gain RERA’s (Real Estate Regulatory Authority’s) permission for the Medicaps Business Park project.
Suheung America Corporation has its EMBO CAPS VG-ALPHA medication delivery device (an empty vegetarian capsule focusing on the pharmaceuticals vertical).

What does the Report say?

The research study is based on source (type-A (pork skin), Type-B gelatin (animal bones & calf skin), and fish bone gelatin), size (size “000” capsules, size “00” capsules, size “0” capsules, size “1” capsules, size “2” capsules, size “3” capsules, size “4” capsules, and size “5” capsules), route of administration (oral administration and inhalation administration), and end-user (pharmaceutical companies, cosmetics & nutraceutical companies, and CROs & CDMOs).
With the fact that hard gelatin capsules demonstrate exceptional protection against oxidation, the Global Hard Gelatin Capsules Industry is expected to grow on a good count in the forecast period.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-14948

Hard Gelatin Capsules Market Key Companies Covered:

ACG Worldwide
Lonza-Capsugel
Qualicaps, Inc. – MITSUBISHI CHEMICAL HOLDINGS CORPORATION
Sunil Healthcare Ltd.
CapsCanada Corporation / Farmacapsulas
Roxlor LLC
Suheung Co., Ltd. – EmboCaps
Medi-Caps Ltd.
NLL – Nectar Lifesciences Ltd.
Natural Capsules
ERAWAT PHARMA

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14948

Key Segments Covered in Hard Gelatin Capsules Market Research

By Source:

Type-A (Pork Skin)
Type-B Gelatin (Animal Bones & Calf Skin)
Fish Bone Gelatin

By Size:

Size “000” Capsules
Size “00” Capsules
Size “0” Capsules
Size “1” Capsules
Size “2” Capsules
Size “3” Capsules
Size “4” Capsules
Size “5” Capsules

By Route of Administration:

Oral Administration
Inhalation Administration

By End User:

Pharmaceutical Companies
Cosmetic & Nutraceutical Companies
CROs & CDMOs

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Lab Accessories Market Booming at 6.8% CAGR, Set to Reach US$1.1 Billion by 2032 | FMI Study

The Lab Accessories Market is experiencing a growth surge, fueled by the ever-increasing demand for advanced scientific research and diagnostics. According to a recent study by Future Market Insights (FMI), a leading market research firm, the market is projected to climb at a robust Compound Annual Growth Rate (CAGR) of 6.8% from 2022 to 2032. This positive trajectory is expected to propel the market to a staggering US$1.1 billion by 2032, signifying a remarkable expansion from its current valuation of US$585.0 million in 2022.

This robust growth is underpinned by several key factors identified in the comprehensive report. The surge is attributed to the increased availability of research funding, rapid technological advancements, and the reverberations of large-scale disease outbreaks. These factors collectively shape a dynamic landscape, presenting an opportune moment for stakeholders within the pharmaceutical and diagnostic industries.

Request a Sample of this Report Now Use Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14938

Moreover, the prevalence of infectious diseases is increasing, leading to a rise in demand for infectious disease diagnosis. In 2016, it was estimated that 36.7 million people were suffering from HIV, as per the World Health Organization. Funding agencies such as Science and Technology Application for Rural Development (STARD) 2015 and Intensification of Research in Higher Priority Areas (IRHPA) 2016 have also increased, which is expected to boost the growth of the global laboratory accessories market in the forecast period since lab accessories are essential for laboratory operations.

Leading Companies Profiled in the Lab Accessories Market are

Thermo Fisher Scientific Inc.
Analytik Jena AG
Biotix Inc.
Vistalab Technologies Inc.
Bio Rad Laboratories Inc.
Brooks Automation Inc.
BD
Corning Incorporated
Greiner Bio-One International GmbH
Hamilton Company
Parker Hannifin Corporation
Heidolph Instruments GmbH & Co. KG
Gilson Inc.
HNP Microsystems GmbH
Verderflex

Key Takeaways from the Lab Accessories Market Study

Global Lab Accessories Industry to nearly double from 2022 to 2032
US to account for the highest value share of US$ 403.0 Million of global market demand for lab accessories in 2032
From 2015 to 2021, lab accessories demand expanded at a CAGR of 7.5%
By type, the wash stations category constitutes the bulk of the lab accessories market with a CAGR of 6.7%.
By end-user, research institutes to be the most prominent end-user, registering a CAGR of 6.9% by 2032

Lab Accessories Market Competitive Landscape

Players in the Global Lab Accessories Industry t focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In June 2022, Becton, Dickinson, and Company introduced the new BD FACSDiscover™ S8 Cell Sorter, featuring the breakthrough BD CellView™ Image Technology. It is the first cell sorter to combine advanced spectral flow cytometry with sort-capable image analysis that will potentially enable researchers to yield more accurate data and sort cells that previously could not be identified.
In June 2021, Bio-Rad Laboratories, Inc. announced the launch of its PREvalence™ ddPCR^® SARS-CoV-2 Wastewater Quantification Kit, a sensitive, accurate, and cost-effective tool used to detect SARS-CoV-2 in a community’s wastewater. ddPCR^® technology is recommended in the Centers for Disease Control and Prevention guidelines (CDC) for wastewater testing, and the use of the technology has been published by the Environmental Protection Agency (EPA) as a dependable method to quantify viruses in wastewater.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/14938

Key Segments Covered in The Lab Accessories Market Study

Lab Accessories Market by Type:

Lab Microplates
Microplate Accessories
Lab Label Printers
Lab Pipettes
Lab Pumps
Lab Reagent Reservoirs
Lab Valves
Lab Tubings
Lab Wash Stations

Lab Accessories Market by End User:

Lab Accessories for OEMs
Lab Accessories for Biotechnology and Pharmaceutical Companies
Lab Accessories for Hospitals and Private Laboratories
Lab Accessories for Academic Institutes
Lab Accessories for Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Curcumin Market Expected to Reach $369.2 Million by 2033 & Anticipates Robust Growth Driven by Rising Demand for Natural Ingredients and Expanding Applications

The global curcumin market is set to experience unprecedented growth over the next decade, with projections indicating a surge from $127.0 million in 2023 to an impressive $369.2 million by 2033. This remarkable expansion, at a compound annual growth rate (CAGR) of 11.3%, is largely attributed to the increasing preference for natural antioxidants and the expanding applications of curcumin across various industries, including food, cosmetics, and pharmaceuticals.

According to the latest industry analysis, the curcumin market is on a rapid growth trajectory, driven by its widespread use in traditional medicine, its potent anti-inflammatory and antioxidant properties, and its growing popularity as a natural food colorant. The global market, valued at $110.6 million in 2022, is expected to reach $127.0 million in 2023, continuing its upward momentum.

Get Your Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14133

Key Drivers of Market Growth:

Rising Demand for Natural Antioxidants: The increasing awareness of the health benefits associated with natural ingredients is a significant driver. Curcumin, known for its anti-oxidation, anti-inflammatory, and anti-cancer properties, is becoming a preferred choice in various end-user industries.
Expanding Applications in Skincare and Cosmetics: Curcumin’s application in skincare and cosmetic products is on the rise due to its effectiveness in treating various skin conditions and its anti-aging properties. This trend is expected to continue, contributing significantly to market growth.
Increased Use in Pharmaceuticals: Curcumin’s therapeutic qualities make it a valuable ingredient in pharmaceuticals, particularly for its role in treating chronic diseases and improving overall health.
Growth in the Food and Beverage Sector: As a natural food colorant, curcumin is widely used in the food and beverage industry, enhancing the appeal and nutritional value of products.

Market Segmentation and Regional Insights

The curcumin market is segmented by nature, form, application, and end-use, with each segment showing promising growth prospects.

By Nature: The conventional segment is expected to dominate the market, accounting for over 87.3% of the total market share in 2021. However, the organic segment is anticipated to register higher growth in the coming years.

By Form: Powdered curcumin is anticipated to reach a valuation of $59.6 million in 2021, driven by its increasing use in personal care products and ready-to-eat food products.

By Application: The antioxidant segment is estimated to hold a dominant share of 30.1% in 2021, fueled by rising consumer preference for natural and organic ingredients.

By End-Use: The herbal and medicinal products segment is expected to grow at an impressive CAGR of 12.0% over the forecast period, driven by the various health benefits of curcumin.

Regional Insights:

North America: Expected to account for $130.8 million by 2033, with significant demand from the pharmaceutical industry and rising popularity of curcumin-based supplements.
Asia Pacific: The fastest-growing market segment, driven by extensive R&D efforts to improve curcumin bioavailability and its growing use in dietary supplements and anti-cancer treatments.
Europe: Anticipated to have a CAGR of 16.7%, supported by well-established personal care and cosmetics industries.

A Detailed Full Report: https://www.futuremarketinsights.com/checkout/14133

Opportunities for Investors

Investors are encouraged to explore the lucrative opportunities presented by the expanding curcumin market. With the increasing demand for natural and organic products, companies are focusing on establishing manufacturing operations close to raw material sources to reduce costs and logistical stress.

Key Players in the Market:

BioMax Life Sciences
Hebei Tianxu Biotech Co., Ltd.
JIAHERB, INC.
Synthite Industries Ltd.
BioThrive Sciences
Herboveda India Pvt. Ltd.
Sabinsa Corporation
The Green Labs LLC
WackerChemie AG
Hindustan Mint & Agro Products Pvt. Ltd.
Arjuna Natural Extracts Ltd.
SV Agrofood
Star Hi Herbs Pvt. Ltd.
Helmigs Prima Sehejtera P.T
SMP Nutra

Authored by:

Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives.

She has exceptional analytical skills and often brings thought leadership to the table.

Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results.

Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor’s Degree in Electrical Engineering from Nagpur University, India.

Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor.

Software Containers Market Set to Surge, Projected to Reach $9.64 Billion by 2032

It is anticipated that the market for software containers would expand quickly, with a CAGR of 11.5%, from US$ 3,256.2 million in 2022 to US$ 9,643.1 million in 2032.

Operating system virtualization is a feature of software containers that enables the operation of applications in data centres and the cloud. Application code and configurations are packaged into distinct building blocks called “software containers” that can be operated in the cloud. These lightweight, functionally effective software containers.

Software containers have a number of benefits, including a quicker configuration cycle, more precise resource control, increased efficiency, and the ability to scale up and down programmes according to demand.

Get Your Copy: Dive into the Forecasted Expansion of the Green Ammonia Market
https://www.futuremarketinsights.com/reports/sample/rep-gb-4805

Software Containers Market: Drivers and Restraints

With cloud computing becoming more mainstream, companies are rapidly adopting software containers for improving the overall efficiency of the application. Software containers also facilitate cost savings by reducing the expenses on hardware Software containers also offer environment consistency because all application files and necessary infrastructure are stored at one place and can be deployed consistently over any environment. Software containers also keep a track of different versions of application code which can help in inspecting the difference between several versions.

One of the major challenges in the software containers market is persistent storage which occurs when containers running databases are used in production setups. Another major challenge to the market is networking issues related to software containers.

Global Software Containers Market Trends

A major trend prevailing in the market is merger and acquisition. In May 2016, Apprenda Inc., a platform as a service (PaaS) cloud software company acquired Kubernetes support company Kismatic, which offered commercial support to Kubernetes. In January 2017, Cisco acquired ContainerX, a privately held company focused on developing enterprise-class container management technology.

Global Software Containers Competitive Landscape

Some of the major software containers vendors include Docker Inc., CoreOS, Codenvy, Inc., Google Inc., Microsoft Corporation, Amazon Web Services, IBM Corporation, Red Hat, Inc., and VMware among others.

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.futuremarketinsights.com/checkout/4805

Regional analysis for Global Software Containers Market includes

North America Software Containers Market
- US
- Canada
Latin America Software Containers Market
- Argentina
- Mexico
- Brazil
- Rest of Latin America
Western Europe Software Containers Market
- Germany
- France
- U.K.
- Spain
- Italy
- Nordic
- Benelux
- Rest of Western Europe
Eastern Europe Software Containers Market
- Poland
- Russia
- Rest of Eastern Europe
Japan Software Containers Market
Middle East and Africa Software Containers Market
- GCC Countries
- North Africa
- South Africa
- Rest of MEA

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Software Containers Market: Market Segmentation

Global Software Containers Market can be divided on the basis of application.

Segmentation on basis of Application for Software Containers Market:

Monitoring and logging
Security
Storage and continuous integration/continuous deployment
Management and orchestration
Networking and data management services

Unleash Your Potential: Customize Your Report to Master the Green Ammonia Market Landscape
https://www.futuremarketinsights.com/customization-available/rep-gb-4805

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Novel Drug Delivery Systems In Cancer Therapy Market Set for Explosive Growth at 19.6% CAGR, Reaching US$88.5 Billion by 2032 | FMI

The Novel Drug Delivery Systems In Cancer Therapy Market is on a fast track to exponential growth, driven by advancements in technology and a growing demand for more effective treatments. According to a recent report by Future Market Insights (FMI), a leading market research firm, the market is projected to reach a staggering US$88.5 billion by 2032. This signifies a remarkable Compound Annual Growth Rate (CAGR) of 19.6% from 2022, highlighting the transformative potential of NDDS in cancer treatment.

This surge signifies a significant rise from the market’s already-established foundation, valued at US$12 billion in 2021. FMI’s analysis highlights the strong momentum propelling the market forward, with a projected CAGR of nearly twice the global pharmaceutical industry’s average growth rate.

Despite the promising future, challenges loom on the horizon. The high cost of therapy is identified as a potential obstacle to the growth of novel drug delivery systems in the cancer therapy market. FMI’s report also highlights concerns about the industry being impeded by a lack of awareness about alternative medications and insufficient funds for their development.

The Global Novel Drug Delivery Systems in the Cancer Therapy Industry have faced the ongoing impact of COVID-19, further influencing market dynamics. Consumer demand has dwindled as individuals prioritize removing non-essential expenses from their budgets, responding to widespread economic challenges resulting from the outbreak.

As the industry navigates these challenges, stakeholders are urged to collaboratively address barriers to growth, fostering innovation and awareness. The projected trajectory, while remarkable, necessitates strategic initiatives to overcome obstacles and unlock the full potential of the Global Novel Drug Delivery Systems in the Cancer Therapy Industry.

Request a Sample of this Report Now Use Work Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14930

Improved therapy by boosting medication efficacy and duration of action, as well as improved patient compliance by reducing dose frequency, are just a few of the factors driving demand for Global Novel Drug Delivery Systems In the Cancer Therapy Industry. To predict unwanted reactions, it allows for correct administration routes and greater targeting for a specific site. Due to increased healthcare awareness, North America is likely to be a dominating region in the novel drug delivery systems in the cancer therapy market.

Novel Drug Delivery Systems In Cancer Therapy Market Key Takeaways:

The novel drug delivery systems in the cancer therapy market are predicted to develop at a CAGR of 19.6%, with a market share of US$ 88.5 billion through 2032.
In the United States, the novel drug delivery systems in the cancer therapy market are estimated to have a CAGR of 19% through 2032, with a market share of US$ 30.6 billion.
The novel drug delivery systems in the cancer therapy market in China are expected to have a prodigious CAGR of 18.7% through 2032, with a market share of US$ 5.9 billion.
The novel drug delivery systems in the cancer therapy market in Japan are expected to have a CAGR of 18.9% through 2032, with a market share of US$ 5.1 billion.
The novel drug delivery systems in the cancer therapy market in the UK are expected to have a CAGR of 18.2% through 2032, with a market share of US$ 3.7 billion.
The novel drug delivery systems in the cancer therapy market in South Korea are expected to have a CAGR of 17.6% through 2032, with a market share of 3.3 billion.
The nanoparticles segment of the novel drug delivery systems in the cancer therapy market, based on products, is expected to grow at an annual rate of 19.2% through 2032.

Novel Drug Delivery Systems In Cancer Therapy Market Competitive Landscape:

Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Galen Limited
Merrimack Pharmaceuticals, Inc
Samyang Biopharmaceuticals Corp., Inc.

Some of the primary measures players are employing to enhance their Global Novel Drug Delivery Systems In the Cancer Therapy Industry share include frequent product launches, geographic expansions, and distribution agreements to expand their consumer base.

Novel Drug Delivery Systems In Cancer Therapy Market Key segments

By Product:

Nanoparticles
Embolization Particles

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-14930

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Diabetic Retinopathy Market Poised for US$15.5 Billion Boom by 2033, Driven by Rising Diabetes Rates

The Diabetic Retinopathy Market is sharpening its focus on the future, with a projected valuation of US$15.50 billion by 2033. This significant growth is fueled by the rising prevalence of diabetes worldwide. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to climb at a robust Compound Annual Growth Rate (CAGR) of 5.8% from 2023 to 2033. This upward trajectory signifies a promising future for diabetic retinopathy diagnosis and treatment solutions.

Crucial information and forecast statistics covered in the Diabetic Retinopathy market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

Request a Sample of this Report Now Use Work Email To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14915

COVID-19 Impact Analysis on Diabetic Retinopathy Market

The recent outbreak of COVID-19 has turned the spotlight on the healthcare industry and subsequently impacted the Diabetic Retinopathy market. Severe shortages of critical medical supplies and a rapid rise in several COVID-19 cases have resulted in a revolution rather than an evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Global Diabetic Retinopathy Industry.

Following government measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on the preliminary impact of COVID-19 on the Diabetic Retinopathy market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports

Grab Your Report on Discount Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-14915

Diabetic Retinopathy Market: Segmentation

Valuable information covered in the FMI’s Global Diabetic Retinopathy Industry report has been segregated into key segments and sub-segments.

By Type:

Proliferative
Non-proliferative

By Management:

Anti-VEGF
Intraocular Steroid Injection
Laser Surgery
Vitrectomy

Diabetic Retinopathy Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Global Diabetic Retinopathy Industry. Competitive information detailed in the Diabetic Retinopathy market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Global Diabetic Retinopathy Industry report.

Key players covered in the report include:

Bayer Healthcare, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc, Oxurion, and others

Important Questions Answered in the Diabetic Retinopathy Market Report

Which end-user remains the top revenue contributor in different regional markets?
At what rate has the Global Diabetic Retinopathy Industry been expanding during the forecast period?
How will the Global Diabetic Retinopathy Industry look like by the end of the forecast period?
What innovative strategies are adopted by Diabetic Retinopathy market players to stay ahead of the pack?
What are the restraints affecting the growth of the Global Diabetic Retinopathy Industry?

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-14915

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis of growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment of the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis of each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with the necessary information to make critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Diabetic Retinopathy market

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Wafer Inspection Market Set to Surge with a Robust CAGR of 10.6%, Reaching Nearly $9.87 Billion by 2032

The wafer inspection market will experience significant growth with a robust CAGR of 10.6% during the projected period. The market value, which was US$ 3598.2 Billion in 2022, is predicted to rise to approximately US$ 9867.7 Million by 2032.

With the development of new electrical goods using integrated circuits, the demand for integrated circuits is rising on a global scale. This directly relates to an increase in wafer demand. Wafers must be timely checked for them to perform more effectively.

The wafer inspection market is now required to manage the correct operation and lengthen the life of wafers. Patterned wafer inspection systems and Non-patterned wafer inspection systems are the detection concepts employed by wafer inspection systems. Due to its uses in a variety of industries, including the industrial segment, consumer electronics, and automation, wafer inspection systems have recently become more powerful as a market. Since wafers and integrated circuits are used in consumer electronics, wafer inspection systems are mostly used in this industry.

Request a Sample Report for Comprehensive Insights
https://www.futuremarketinsights.com/reports/sample/rep-gb-4900

Wafer Inspection System Market: Drivers and Restraints:
The primary driver for the wafer inspection system market is the increasing adoption and introduction of new electrical gadgets such as smartphones, laptops, tablets, wearables, LCDs, LEDs, etc., as it directly increases the demand for wafer inspection systems. Moreover, the advantages attained such as longer wafer life, timely detection of defects and enhanced performance encourage the adoption of wafer inspection systems.

In addition to this, the emerging manufacturers with new technological innovations, in North America and Europe drive the global wafer inspection system market.

The trend of miniaturization in wafer manufacturing is compelling wafer inspection system providers to upgrade their offerings. This is acting as one of the major restraints for the wafer inspection system market. Additionally, the limited availability of manufacturers and resources also acts as a challenge for the global wafer inspection system market.

Global Wafer Inspection System Market Technology Regional Overview:
APAC dominates the global wafer inspection system market due to the presence of the majority of its manufacturers in the respective region. Because of the technological advancements made, in the same, North America and Europe are expected to follow APAC in the global wafer inspection system market.

Leading Key Players:
Applied Materials, Inc., KLA-Tencor Corporation, ASMA, Hermes Microvision, Inc., Hitachi High-Technologies Corporation, Lam Research Corporation, Nanda Technologies GmBH, NXP Semiconductors, Taiwan Semiconductor Manufacturing Company Limited, Synopsys

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.futuremarketinsights.com/checkout/4900

Key Segments Profiled in the Wafer inspection Market Survey

By Technology:

E-beam detection technology
Optical detection technology

By Defect Type:

Random defects detection
Systematic defects detection

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Author:

About Future Market Insights (FMI)

Contact Us:

Epinephrine Auto-Injectors Market Set for Lifesaving Growth at 4.9% CAGR, Reaching US$3.2 Billion by 2032 | FMI Study

The Epinephrine Auto-Injectors Market is poised for a surge, driven by a growing emphasis on allergy awareness and preparedness. According to a recent industry report by Future Market Insights (FMI), a leading market research firm, the market is expected to climb from US$2 billion in 2022 to an impressive US$3.2 billion by 2032. This upward trajectory signifies a compelling Compound Annual Growth Rate (CAGR) of 4.9%, highlighting the increasing importance of these life-saving devices.

This upward trajectory is fueled by the increasing demand for epinephrine auto-injectors, driven by notable advancements in syringe and injector technologies. Responding to evolving clinical and patient needs, manufacturers within the industry have demonstrated significant innovation, contributing significantly to the burgeoning market.

One of the driving forces behind this growth is the escalating prevalence of allergies worldwide. Individuals facing allergic reactions to dust, insect bites, venom, food, and food additives have significantly contributed to the expanding market for epinephrine auto-injectors. As a result, the industry is witnessing a surge in opportunities and a widening consumer base.

Furthermore, vendor investments in research and development initiatives have played a pivotal role in shaping key trends and opportunities within the Global Epinephrine Auto-Injectors Industry. A noteworthy development includes the creation of chlorofluorocarbon-free epinephrine auto-injector inhalers using hydrofluoroalkanes as propellants. This environmentally conscious approach not only aligns with global sustainability goals but also propels the industry into a new era of innovation.

Request a Sample of this Report Now Use Work Mail To Get Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14876

However, excessive use of epinephrine can lead to adverse side effects such as cardiac arrhythmia, pulmonary edema, vomiting, and brain hemorrhage, which may pose a challenge for the Global Epinephrine Auto-Injectors Industry.

During the forecast period, the regional market for epinephrine auto-injectors is expected to be driven by the increasing number of people suffering from various types of allergies, the availability of low-cost generic epinephrine auto-injectors, and the high adoption rate of epinephrine auto-injectors in the United States. The adoption trends in the epinephrine auto-injector market are also expected to contribute to its growth.

Epinephrine Auto-Injectors Market Key Takeaways:

In the United States, the epinephrine auto-injectors market size is estimated to reach US$ 1.2 Billion by 2032, increasing at a CAGR of 4.7% through 2032.
The epinephrine auto-injectors market share in the United Kingdom is expected to be worth US$ 132.9 Million by 2032, with a CAGR of 3.6% through 2032.
China’s epinephrine auto-injectors market share is expected to reach US$ 233.7 Million by 2032, with a CAGR of 4.2% through 2032.
The market share for epinephrine auto-injectors in Japan is expected to be valued at US$ 188.5 Million by 2032, expanding at a 3.3% annual rate through 2032.
South Korea is expected to reach a market size of US$ 117.6 Million in epinephrine auto-injectors by 2032, with a CAGR of 2.8% through 2032.
The epinephrine auto-injectors market’s Hospitals segment from the end user category is predicted to develop at a CAGR of 4.8% through 2032.
Through 2032, the 0.3 mg sector in the epinephrine auto-injectors market’s dosage category will grow at a CAGR of 4.9%.

Epinephrine Auto-Injectors Market Competitive Landscape:

A new market research report on epinephrine auto-injectors says that Adamis Pharmaceuticals Corporation, Alk-Abello A/S, Impax Laboratories, Inc., Mylan N.V., and Antares Pharma is among the legacy player’s vendors.

The research offers a comprehensive competition analysis of these top competitors in the epinephrine auto-injectors market, including Global Epinephrine Auto-Injectors Industry growth, epinephrine auto-injectors market share, Global Epinephrine Auto-Injectors Industry adoption trends and important market strategies.

Recent Development in the Epinephrine Auto-Injectors Market:

Antares Pharma (US) struck an arrangement with Lunatus Global Medical Supplies in August 2020. (Dubai). Antares will deliver packaged goods to Lunatus under this arrangement, and Lunatus will submit and get regulatory permission for XYOSTED in the UAE and Saudi Arabia, as well as promote, market, and distribute XYOSTED in these two countries.
SHL Medical (Switzerland) bought Weibel CDS in March 2020. (Switzerland). The goal of this purchase was to increase SHL Medical’s capacity to develop more sophisticated medication delivery systems based on human-centered designs and functionality.
Eli Lilly spent US$ 470 million and generated approximately 460 new jobs in Durham, NC in January 2020. With this extension, North Carolina’s Research Triangle Park gained a new state-of-the-art pharmaceutical production plant.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/14876

Epinephrine Auto-Injectors Market Key Segments:

By End-User:

Hospitals
Clinics
Home Based
Others

By Dosage:

0.15 mg
0.3 mg
Others

By Age Group:

0-4 Years
5-14 Years
15-24 Years
25-49 Years
50-64 Years
Above 65 Years

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: